Literature DB >> 6651790

Serum glycoconjugates in children with schizophrenia and conduct and adjustment disorders.

R Varma, G A Michos, B J Gordon, R S Varma, R E Shirey.   

Abstract

The serum glycoproteins represented by the individual protein-bound carbohydrate components and glycosaminoglycans represented by the hexuronic acid contents were determined in the sera of black and Caucasian normal children and children with diagnoses of schizophrenia, conduct disorder, and adjustment disorder. There were no race-related or sex-related differences in glycoproteins and glycosaminoglycans in the sera of normal children. Although the serum glycosaminogltents were determined in the sera of black and Caucasian normal children and children with diagnoses of schizophrenia, conduct disorder, and adjustment disorder. There were no race-related or sex-related differences in glycoproteins and glycosaminoglycans in the sera of normal children. Although the serum glycosaminogltents were determined in the sera of black and Caucasian normal children and children with diagnoses of schizophrenia, conduct disorder, and adjustment disorder. There were no race-related or sex-related differences in glycoproteins and glycosaminoglycans in the sera of normal children. Although the serum glycosaminoglycans were significantly elevated in children with a diagnosis of schizophrenia, the levels were in normal range in children with conduct and adjustment disorders. All of the protein-bound carbohydrates were elevated in schizophrenic children. However, only arabinose and galactosamine were significantly elevated in children with a diagnosis of conduct disorder, while only galactosamine was elevated in children with adjustment disorder. The presence of arabinose in serum glycoprotein was confirmed by chemical ionization-mass spectrometry. The possible causes of the differential elevation of the glycoconjugates in psychiatric disorders in relation to the effect of stress and environment are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651790     DOI: 10.1016/0006-2944(83)90087-x

Source DB:  PubMed          Journal:  Biochem Med        ISSN: 0006-2944


  3 in total

1.  Fluorescent liposomes for differential interactions with glycosaminoglycans.

Authors:  Erin K Nyren-Erickson; Manas K Haldar; Yan Gu; Steven Y Qian; Daniel L Friesner; Sanku Mallik
Journal:  Anal Chem       Date:  2011-06-30       Impact factor: 6.986

Review 2.  Post-translational protein modifications in schizophrenia.

Authors:  Toni M Mueller; James H Meador-Woodruff
Journal:  NPJ Schizophr       Date:  2020-03-02

Review 3.  Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers.

Authors:  Firas Kobeissy; Abir Kobaisi; Wenjing Peng; Chloe Barsa; Mona Goli; Ahmad Sibahi; Samer El Hayek; Samar Abdelhady; Muhammad Ali Haidar; Mirna Sabra; Matej Orešič; Giancarlo Logroscino; Stefania Mondello; Ali H Eid; Yehia Mechref
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.